Klaus Edvardsen

Chief Tech/Sci/R&D Officer at NYKODE THERAPEUTICS

64 year

Health Technology

Consumer Services

Finance

Profile

Klaus Edvardsen currently works at Merck Ventures BV, as Senior Vice President and Nykode Therapeutics ASA, as Chief Research & Development Officer from 2022.
Dr. Edvardsen also formerly worked at AstraZeneca PLC, as SVP& Head-Global Medicines Development Oncology and CureVac NV, as Chief Development Officer from 2021 to 2022.
Dr. Edvardsen received his doctorate degree from the University of Copenhagen.

Klaus Edvardsen active positions

Companies	Position	Start
NYKODE THERAPEUTICS	Chief Tech/Sci/R&D Officer	2022-06-30
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Private Equity Investor	-

All active positions of Klaus Edvardsen

Former positions of Klaus Edvardsen

Companies	Position	End
CUREVAC	Corporate Officer/Principal	2022-06-29
ASTRAZENECA PLC	Corporate Officer/Principal	-

See the detail of Klaus Edvardsen's experience

Training of Klaus Edvardsen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Klaus Edvardsen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Finance
CureVac NV CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies	Health Technology